Sleep Optimization Peptide Protocol
Research protocol for studying sleep-related peptides including DSIP (Delta Sleep-Inducing Peptide) and Epithalon, covering their chronobiological mechanisms, evening administration timing, and sleep quality assessment frameworks.
Materials Needed
- Reconstituted DSIP
- Reconstituted Epithalon
- Insulin syringes
- Alcohol swabs
- Sleep tracking device or app (wearable preferred)
- Pittsburgh Sleep Quality Index (PSQI) questionnaire
- Research log
Dosing Calculator
Calculate the injection volume needed for your target dose.
Result:
Injection Volume
0.100 mL
Syringe Units (U-100)
10.0 units
Doses Per Vial
20
Concentration: 2500 mcg/mL (2.50 mg/mL)
Understand Sleep Peptide Mechanisms
DSIP (Delta Sleep-Inducing Peptide) is a nine-amino-acid neuropeptide that modulates sleep architecture by promoting delta-wave (slow-wave) sleep stages, with additional effects on ACTH and cortisol regulation. It was originally isolated from cerebral venous blood of rabbits during electrically-induced sleep. Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) analog of the pineal gland peptide epithalamin, which stimulates telomerase activity and melatonin production by the pineal gland, thereby normalizing circadian rhythm function.
Tips
- • DSIP acts on sleep architecture directly, while Epithalon works indirectly by restoring endogenous melatonin production
- • These peptides address different aspects of sleep dysfunction — DSIP for sleep depth, Epithalon for circadian rhythm regulation
Establish Sleep Baseline
Before beginning the protocol, collect at least 7 days of baseline sleep data. Use a wearable sleep tracker (smartwatch, Oura ring, or similar) to record total sleep time, sleep latency (time to fall asleep), number of awakenings, and sleep stage distribution (light, deep, REM). Complete the Pittsburgh Sleep Quality Index (PSQI) questionnaire for a standardized subjective baseline. Document caffeine intake timing, screen exposure, room temperature, and other sleep hygiene variables.
Estimated time: 7 days (baseline collection period)
Do not change sleep hygiene habits during baseline collection — the goal is to capture your actual current sleep pattern
Tips
- • The PSQI is a validated 19-item self-report questionnaire widely used in sleep research
- • Wearable trackers are not perfectly accurate for sleep staging but provide consistent relative measurements over time
Review Dosing and Timing
Literature-based research doses: DSIP at 100-300 mcg subcutaneously, administered 30-60 minutes before planned sleep onset. Epithalon at 5-10 mg subcutaneously, administered in the evening (typically 2-3 hours before sleep). Epithalon is often studied in 10-20 day courses followed by 4-6 month rest periods, reflecting the Khavinson laboratory's protocol for pineal peptides. DSIP can be administered nightly or on a 5-days-on, 2-days-off schedule.
Tips
- • DSIP's short half-life (~15-25 minutes) means timing relative to sleep onset is important
- • Epithalon's effects on melatonin production persist beyond the administration period — it restores function rather than providing exogenous melatonin
Administer Evening Peptides
Follow the Subcutaneous Injection Technique Protocol. For DSIP: inject 30-60 minutes before planned sleep time. For Epithalon: inject 2-3 hours before sleep. If using both, administer Epithalon first (earlier in the evening), then DSIP closer to bedtime. Use the abdominal subcutaneous site and rotate injection locations.
Estimated time: 5 minutes
Do not mix DSIP and Epithalon in the same syringe
Tips
- • Prepare syringes earlier in the evening so the process is not rushed at bedtime
- • Dim lighting during evening administration aligns with circadian optimization
Maintain Consistent Sleep Environment
Control sleep hygiene variables throughout the research period to isolate the peptide effects. Maintain consistent sleep/wake times (within 30 minutes), room temperature (65-68°F / 18-20°C), darkness level (blackout curtains or sleep mask), and a consistent pre-sleep routine. Avoid caffeine after 2:00 PM and limit blue light exposure 1-2 hours before bed.
Tips
- • Sleep environment consistency is the most important confounding variable to control
- • Document any deviations from the standard environment in your research log
Collect Nightly Data
Each morning upon waking, record: time to bed, estimated sleep latency, number of awakenings, time of final waking, subjective sleep quality (1-10 scale), subjective dream vividness (1-10), and morning alertness (1-10). Cross-reference with wearable tracker data. Note any DSIP-specific observations — the literature reports increased dream vividness and improved sleep continuity.
Estimated time: 5 minutes each morning
Tips
- • Record subjective data immediately upon waking, before checking your phone or tracker data, to avoid bias
- • DSIP research commonly reports increased delta-wave sleep — look for changes in 'deep sleep' percentage on your tracker
Evaluate Protocol Outcomes
After the planned research period (minimum 2 weeks for DSIP, full course for Epithalon), compile all sleep data. Compare against the 7-day baseline using averages for each metric. Complete the PSQI questionnaire again and compare scores. Calculate changes in total sleep time, sleep efficiency (time asleep / time in bed), deep sleep percentage, and sleep latency.
Tips
- • Present data as weekly averages to smooth night-to-night variability
- • Epithalon's effects on melatonin production may continue improving for weeks after the administration course ends — consider extended follow-up
Related Monographs
DSIP
A comprehensive review of Delta Sleep-Inducing Peptide (DSIP), a naturally occurring nonapeptide involved in sleep architecture modulation, circadian rhythm regulation, neuroendocrine function, stress adaptation, and antioxidant defense, including pharmacokinetics, safety profile, and dosing in research.
Read monographEpithalon
An in-depth review of Epithalon (Epitalon), a synthetic tetrapeptide based on the pineal gland peptide epithalamin, covering its role in telomerase activation, telomere elongation, anti-aging research, melatonin regulation, pharmacokinetics, and safety profile.
Read monographRelated Protocols
Cognitive Peptide Research Protocol
Research protocol for nootropic peptide compounds including Selank, Semax, and Dihexa, covering nasal and subcutaneous administration routes, cycling strategies, and cognitive assessment considerations.
Anti-Aging Peptide Research Protocol
Research protocol for longevity-focused peptide compounds including Epithalon, NAD+ precursors, MOTS-c, and GHK-Cu, covering cycling strategies, biomarker tracking, and combination approaches from published gerontological research.
GHRP + GHRH Combination Protocol
Research protocol for combining growth hormone-releasing peptide (GHRP) with growth hormone-releasing hormone (GHRH) analogs to achieve synergistic GH release, including timing, dosing rationale, and monitoring considerations.
BPC-157 + TB-500 Healing Combination Protocol
Research protocol for combining BPC-157 and TB-500 (Thymosin Beta-4) for synergistic tissue healing research, covering dosing rationale, administration timing, and the complementary mechanisms of these two healing peptides.